Learning Tracks

This session will include discussion of how to better integrate the patient perspective in generic drug and biosimilars development, regulatory assessment, and in the policy environment. Panelists will discuss best practices for supporting patients and patient advocacy groups and the education of healthcare practitioners on biosimilars to help enact patient-forward changes in the context of access, human factors and product usability, and beyond.